학술논문
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
Document Type
Article
Author
Source
JAMA Ophthalmology; Jun2023, Vol. 141 Issue 6, p554-561, 8p
Subject
Language
ISSN
21686165